Skip to main content
SpringerLink
Log in

Unbehandelter Typ-1-Diabetes

Extreme Hypertriglyzeridämie

  • Fortbildung
  • Lipidsprechstunde
  • Published:
CardioVasc Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Li Y, He PP, Zhang DW, Zheng XL, Cayabyab FS, Yin WD et al. Lipoprotein lipase: from gene to atherosclerosis. Atherosclerosis. 2014;237(2):597–608

    Article  CAS  PubMed  Google Scholar 

  2. Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol. 2014;2(8):655–66

    Article  CAS  PubMed  Google Scholar 

  3. Nordestgaard BG. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. Circ Res. 2016;118(4):547–63

    Article  CAS  PubMed  Google Scholar 

  4. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;253:281–344

    Article  CAS  PubMed  Google Scholar 

  5. Sparks JD, Sparks CE, Adeli K. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2012;32(9):2104–12

    Article  CAS  PubMed  Google Scholar 

  6. Kuchay MS, Farooqui KJ, Bano T, Khandelwal M, Gill H, Mithal A et al. Heparin and insulin in the management of hypertriglyceridemia- associated pancreatitis: case series and literature review. Arch Endocrinol Metab. 2017, doi: 10.1590/2359-3997000000244

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Klinische Chemie und Laboratoriumsmedizin, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106, Freiburg, Deutschland

    Michael M. Hoffmann

  2. Institut für Klinische Chemie und Laboratoriumsmedizin, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland

    Brigitte König &  Karl Winkler

Authors
  1. Michael M. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brigitte König
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karl Winkler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael M. Hoffmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoffmann, M.M., König, B. & Winkler, K. Extreme Hypertriglyzeridämie. CV 17, 26–27 (2017). https://doi.org/10.1007/s15027-017-1140-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-017-1140-y

Search

Navigation